Last Updated:
Name Designation Appointment Date Status
Inderjeet Singh Negi

Appointed as Director since November 2009

Director 25-Nov-2009 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Amit Indubhushan Bakshi

Appointed as Director since July 2009

Director 30-Jul-2009 Current
Kaushal Kamlesh Shah

Appointed as Director since November 2009

Director 25-Nov-2009 Current

People Timeline

Explore the timeline of key personnel in Eris Therapeutics Private Limited's leadership journey.

Loading...
Contact Details
  • Address Vision 2020, Sf-209, 150Ft Ring Road, Nr. Lijjat Papad, Plt-3-4,, Rajkot Gujarat, 360007, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
How can I contact Eris Therapeutics Private Limited?
You can contact Eris Therapeutics Private Limited through their registered address at Vision 2020, Sf-209, 150Ft Ring Road, Nr. Lijjat Papad, Plt-3-4,, Rajkot Gujarat, 360007, India, or via their website at erislifesciences.com. Social media links are also provided where applicable.
Who are the current directors of Eris Therapeutics Private Limited?
The current directors of Eris Therapeutics Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • INDERJEET SINGH NEGI
  • AMIT INDUBHUSHAN BAKSHI
  • KAUSHAL KAMLESH SHAH
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available